MAGNANI, CHIARA FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 4.026
AS - Asia 1.901
EU - Europa 1.660
SA - Sud America 272
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 7.920
Nazione #
US - Stati Uniti d'America 3.866
SG - Singapore 691
CN - Cina 401
IT - Italia 352
VN - Vietnam 263
HK - Hong Kong 255
DE - Germania 237
RU - Federazione Russa 208
BR - Brasile 200
SE - Svezia 196
IE - Irlanda 156
CA - Canada 131
GB - Regno Unito 112
FR - Francia 85
UA - Ucraina 82
IN - India 53
FI - Finlandia 43
PL - Polonia 35
ES - Italia 33
NL - Olanda 32
BD - Bangladesh 31
TR - Turchia 27
AR - Argentina 26
PK - Pakistan 24
BE - Belgio 22
ID - Indonesia 22
ZA - Sudafrica 20
JP - Giappone 19
KR - Corea 19
MX - Messico 18
DK - Danimarca 17
IQ - Iraq 17
CH - Svizzera 15
PH - Filippine 14
SA - Arabia Saudita 14
VE - Venezuela 12
TN - Tunisia 9
CO - Colombia 8
EC - Ecuador 8
AT - Austria 7
MY - Malesia 7
UZ - Uzbekistan 7
NP - Nepal 6
EU - Europa 5
MA - Marocco 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
CL - Cile 4
PY - Paraguay 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
IL - Israele 2
JM - Giamaica 2
LK - Sri Lanka 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
IR - Iran 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
ZW - Zimbabwe 1
Totale 7.920
Città #
Ann Arbor 475
Ashburn 392
Singapore 353
Woodbridge 269
Chandler 251
Hong Kong 244
Fairfield 236
Houston 211
San Jose 193
Wilmington 161
Frankfurt am Main 154
Dublin 150
Milan 102
Cambridge 101
Seattle 99
Dearborn 92
Jacksonville 88
Ho Chi Minh City 86
New York 81
Santa Clara 76
Toronto 66
Los Angeles 63
Chicago 57
Dallas 55
Beijing 53
Hanoi 51
Princeton 49
The Dalles 45
Nanjing 43
Shanghai 35
Hefei 32
Buffalo 27
Lauterbourg 27
Council Bluffs 25
Lissone 25
Montreal 23
Lawrence 22
São Paulo 22
Brussels 21
Denver 18
Kraków 18
Lachine 16
Altamura 15
Brooklyn 15
Helsinki 15
Stockholm 15
Warsaw 15
Boardman 14
Da Nang 14
Munich 14
Nanchang 14
Seoul 14
Tokyo 14
Johannesburg 13
London 12
Moscow 12
Orem 12
San Francisco 12
Amsterdam 11
Jakarta 11
Manchester 11
Phoenix 11
Zurich 11
Fremont 10
Poplar 10
Rome 10
Hangzhou 9
Jiaxing 9
San Diego 9
Dong Ket 8
Haiphong 8
Hải Dương 8
Jinan 8
Pavia 8
Turku 8
Andover 7
Belo Horizonte 7
Bergamo 7
Boston 7
Dhaka 7
Florence 7
Guangzhou 7
Hebei 7
Jeddah 7
Shenyang 7
Tampa 7
Tashkent 7
Zhengzhou 7
Ankara 6
Atlanta 6
Baghdad 6
Brescia 6
Chennai 6
Curitiba 6
Genoa 6
Istanbul 6
Kunming 6
Taizhou 6
Biên Hòa 5
Columbus 5
Totale 5.148
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 427
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 419
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 406
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 379
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 354
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 347
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 342
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 336
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 328
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives 286
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 286
Acquired glucose sensitivity of k-ras transformed fibroblasts 274
Donor-derived CD19-targeted T cells in allogeneic transplants 273
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 270
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells 268
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 266
Type 1 regulatory T cells: cytotoxic activity and molecular signature 264
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor 257
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 252
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells 244
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells 236
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 227
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway 222
Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations 203
Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells 200
The Past, Present, and Future of Non-Viral CAR T Cells 191
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 176
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo 170
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 118
null 78
Totale 8.099
Categoria #
all - tutte 23.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 33 59
2021/2022403 28 36 52 27 32 22 13 17 32 42 29 73
2022/2023792 89 229 105 71 40 112 9 44 59 4 24 6
2023/2024488 15 17 28 42 52 95 94 39 35 14 13 44
2024/20251.081 59 99 47 43 91 32 77 30 144 166 94 199
2025/20262.903 372 143 211 386 448 197 437 117 242 243 107 0
Totale 8.099